Galmed Pharmaceuticals
GLMD
GLMD
20 hedge funds and large institutions have $878K invested in Galmed Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$17.4K | |
| 2 | +$13K | |
| 3 | +$10.1K | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$5.62K |
| 5 |
AF
Allworth Financial
Folsom,
California
|
+$107 |
Top Sellers
| 1 | -$167K | |
| 2 | -$7.51K | |
| 3 | -$7.26K | |
| 4 |
Jane Street
New York
|
-$6.01K |
| 5 |
SG
StoneX Group
New York
|
-$5.28K |